MT-Keyboard:贝叶斯模型辅助的间隔设计,以考虑I期试验中的毒性等级和类型
Kai Chen1, Li Wang2, Ying Yuan3
1Department of Biostatistics and Data Science, The University of Texas Health Science Center, Houston, TX, USA.
Statistics in biopharmaceutical research
|January 29, 2025
概括
这项研究介绍了MT-Keyboard设计,这是一种用于剂量发现试验的新贝叶斯方法. 它有效地结合了各种毒性等级和类型,改进了只关注严重毒性的传统方法.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 瘤学 药物开发 药物开发
背景情况:
- 传统的剂量检测试验依赖于剂量限制性毒性 (DLT),通常缺乏新疗法的毒性.
- 定义为严重不良事件 (3级+) 的DLT,对于具有低毒性的向疗法和免疫疗法是不够的.
- 项目最佳化和ASA BIOP论坛强调需要在瘤学中改进剂量优化和选择.
研究的目的:
- 提出一种新的模型辅助贝叶斯设计,即MT键盘,用于剂量发现.
- 除了DLT之外,还要纳入各种毒性信息 (等级和类型).
- 为了扩大设计的晚发性毒性 (TITE-MT-键盘).
主要方法:
- 引入了多重毒性键盘 (MT-Keyboard) 的贝叶斯设计.
- 适应二进制,准二进制和持续毒性终点.
- 开发了TITE-MT-Keyboard扩展,用于使用近似概率进行晚发性毒性.
主要成果:
- 模拟显示了MT-Keyboard和TITE-MT-Keyboard的理想操作特性.
- 拟议的设计性能与现有方法相比或更好.
- 基于Web的软件可以在www.trialdesign.org.org上实现.
结论:
- MT-Keyboard的设计提供了一种有效且易于实施的剂量发现方法.
- 这种设计提高了通过考虑多种等级和类型来表征药物毒性的能力.
- TITE-MT-Keyboard扩展解决了临床试验中晚发性毒性的挑战.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
Pharmacokinetic Models: Comparison and Selection Criterion
490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
Kaplan-Meier Approach
792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792


